Aptamino
New York · Founded 2023
About Aptamino
Aptamino is a biotechnology company that enables oral antibody delivery utilizing protein design.
Company Facts
- Founded: 2023
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Total funding: $8.0M
- Funding stage: Seed
- Last round: Pre-Seed (Jun 2024)
- Website: aptamino.com
Canonical: https://fsome.com/organization/aptamino-8454654 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.